🇪🇸 Spain · EU Public Tender
Medicamentos exclusivos: glucosidasa alfa (Myozyme), vandetanib (Caprelsa), rasburicasa (Fasturtec), inmunoglobulina antitimocítica (Timoglobulina). Prórroga PNSP 28/2019
🏛️ Servicio Madrileño de Salud, Hospital Universitario La Paz · 📍 Madrid
1.1M €
Estimated value
—
Deadline
| Contract type | Supplies |
| CPV | 33600000 |
| Awarded to | Sanofi-Aventis |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.